Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Retatrutide (LY3437943) is a once-weekly injection that activates three different hormone receptors at the same time: GLP-1 (Glucagon-Like Peptide-1) receptor - controls blood sugar and appetite GIP (Glucose-Dependent Insulinotropic Polypeptide) receptor - enhances insulin release and metabolism Glucagon receptor - increases energy expenditure and fat burning Think of it like this: Semaglutide (Ozempic) = Single agonist (GLP-1 only) Tirzepatide (Mounjaro) = Dual agonist (GLP-1 + GIP) Retatrutide = Triple agonist (GLP-1 + GIP + Glucagon) Each added receptor appears to amplify the benefits
Its growing relevance in scientific studies reflects the increasing demand for compounds that allow broader and more integrated metabolic research
Now, if you're new here
Can I take Wegovy with a statin
